Search results (12)
« Back to PublicationsPlasma periaxin is a biomarker of peripheral nerve demyelination
Journal article
Bellanti R. et al, (2025), Brain, 148, 4448 - 4460
Chronic Inflammatory Demyelinating Polyradiculoneuropathy ( CIDP ) Developing During Tacrolimus Treatment: A Case Series
Journal article
Evans MC. et al, (2025), Muscle & Nerve, 72, 1289 - 1293
Enhanced adenoviral reactivity in Guillain-Barré syndrome after SARS-CoV-2 infection and vaccination
Journal article
Bellanti R. et al, (2025), Brain
Diagnosis and Management of Multifocal Motor Neuropathy in the United Kingdom: A Multicentre Survey
Journal article
Rajabally YA. et al, (2025), Journal of the Peripheral Nervous System, 30
Guillain‐Barré syndrome: a comprehensive review
Journal article
Bellanti R. and Rinaldi S., (2024), European Journal of Neurology, 31
Ultrasensitive assay technology and fluid biomarkers for the evaluation of peripheral nerve disease
Journal article
Bellanti R. et al, (2024), Journal of Neurology, Neurosurgery & Psychiatry, 95, 114 - 124
Reply: Peripherin is a biomarker of axonal damage in Guillain-Barré syndrome: a pathophysiological annotation
Journal article
Keddie S. et al, (2024), Brain, 147, e3 - e4
AL amyloidosis presenting with isolated lumbosacral radiculoplexus neuropathy
Journal article
Bellanti R. et al, (2023), Practical Neurology, 23, 516 - 518
Peripherin is a biomarker of axonal damage in peripheral nervous system disease
Journal article
Keddie S. et al, (2023), Brain, 146, 4562 - 4573
Cancer antigen-125 and risk of atrial fibrillation: a systematic review and meta-analysis
Journal article
Cheung A. et al, (2018), Heart Asia, 10, e010970 - e010970
Pericardial actinomycosis in a patient with oesophageal dysmotility and autoantibodies
Journal article
Bellanti R. et al, (2017), British Journal of Hospital Medicine, 78, 472 - 473